Clinical Trials Logo

Clinical Trial Summary

Telephone, internet-connected devices (phablet, pc), chat platforms, mobile applications (Skype, Facebook messenger, Whatsapp, to name a few) can be exploited for telemedicine applications. Whatsapp and similar applications are widely used to facilitate clinical communication between physicians, too. Moreover, Whatsapp is used between ED physicians and consultant physicians during ED consultations in which medical information is exchanged. This platform is regarded as a useful application in the consultation of dermatological and orthopaedic cases. Preventing the overcrowding in the ED is key to reducing the transmission risk, and teleconsulting practice is thought to be effective in the diagnosis, treatment and reduction of the risk of disease transmission, most notably in the Covid-19 pandemic process. Video consulting is highly recommended in some countries on the grounds that it is likely to reduce the risk of transmission. Whatsapp-like applications are one of the video-consulting platforms assumed to reduce the risk of contamination by minimizing the patient-doctor contact. This study thus sets out to investigate the effect of Whatsapp video consultation upon patient admission and discharge times in comparison to bedside consultation in the evaluation of potential Covid-19 patients visiting the Covid-19 outpatient clinic during the pandemic period. The subjects who presented to ED Covid-19 outpatient clinic between March 11, 2020 and May 31, 2020 and for whom an infectious diseases (ID) physician was consulted (via Whatsapp or at bedside) will be included in the study in accordance with the inclusion and exclusion criteria. Eventually, 54 patients whose consultations were made via Whatsapp and 90 patients whose consultations were made at bedside will be in this study.


Clinical Trial Description

Telephone, internet-connected devices (phablet, pc), chat platforms, mobile applications (Skype, Facebook messenger, Whatsapp, to name a few) can be exploited for telemedicine applications. Whatsapp and similar applications are widely used to facilitate clinical communication between physicians, too. Moreover, Whatsapp is used between ED physicians and consultant physicians during ED consultations in which medical information is exchanged. This platform is regarded as a useful application in the consultation of dermatological and orthopaedic cases. Preventing the overcrowding in the ED is key to reducing the transmission risk, and teleconsulting practice is thought to be effective in the diagnosis, treatment and reduction of the risk of disease transmission, most notably in the Covid-19 pandemic process. Video consulting is highly recommended in some countries on the grounds that it is likely to reduce the risk of transmission. Whatsapp-like applications are one of the video-consulting platforms assumed to reduce the risk of contamination by minimizing the patient-doctor contact. Even though some studies on Whatsapp consultation in ED exist in the literature, we did not encounter any study investigating the effect of Whatsapp-mediated consultation on pandemic polyclinics. This study thus sets out to investigate the effect of Whatsapp video consultation upon patient admission and discharge times in comparison to bedside consultation in the evaluation of potential Covid-19 patients visiting the Covid-19 outpatient clinic during the pandemic period. During the coronavirus pandemic process, the patients were consulted with the ID department through the bedside consultation method or video transmission from Whatsapp. The consultation method of the patients will be scanned retrospectively (from the fixed ED phone and the hospital system) and will be recorded in the dataset. The method of consultation through video transmission will be implemented at the beginning of the pandemic process to increase communication between the emergency service and the infectious diseases department. Duration of video that send on whatsapp for consultation, infection diseases specialist response to video, clinician's response to bedside consultation was saved to dataset. Besides, time from patients application to CT, time from patients application to lab results, duration of patients in emergency service, and time periods of consultation (within working hour [8:00-17:00], or out of working hours [17:00-08:00]) will be also saved. The subjects who presented to ED Covid-19 outpatient clinic between March 11, 2020 and May 31, 2020 and for whom an infectious diseases (ID) physician was consulted (via Whatsapp or at bedside) will be included in the study in accordance with the inclusion and exclusion criteria. In this cohort, the subjects whose consultations will be held before admission to another department, and the subjects inflicted with problems involving multiple departments were excluded from the study.In order to isolate potential Covid-19 patients during the pandemic process, these patients were examined at the Covid-19 outpatient clinic under the supervision of ED. Following their examination here, the consultation of those conforming to the potential Covid-19 patient classification will be held with ID department. The potential Covid-19 patients were assessed by an ED physician as specified in the Potential Covid-19 Cases Guide of Ministry of Health. In the Covid-19 pandemic period, not every consultation could be performed at bedside because both ED and ID physicians worked at a schedule twice as busy as normal times in relation to the congestion of working conditions and the organization of pandemic areas. During this pandemic process, consultations via Whatsapp emerged naturally due to the overcrowding in the pandemic outpatient clinic. The eligible subjects examined by the ED physician who consulted an ID physician at the bedside or via Whatsapp will be evaluated in the study. Whatsapp Consultation The ID physician was consulted for all the subjects once laboratory results and CT reports were complete. All the consultations were performed with the same smartphone, and every Whatsapp consultation held since the very beginning of the pandemic will be evaluated. In this type of consultation, Thorax CT images of the patient were turned into a video of approximately 30-35 seconds, and during this video recording, the patient's clinical condition and laboratory results will be also transferred to the ID physician. The ID physician, on the other hand, stated his/her admission-discharge decision via Whatsapp as "hospitalization" or "discharge". Eventually the consultation result will be recorded in the patient's folder. The moment the video was sent will be recorded as the beginning of the patient's consultation period and response time to whatsapp video was saved as consultation response time. The exclusion criteria in the present study can be listed as follows: the subjects whose consultations were held before admission to another department, the subjects inflicted with problems involving multiple departments and whose consultations were performed via Whatsapp, the subjects whose consultations were held by sending photos, the subjects who were referred from another outpatient clinic and whose consultation procedures were completed in ED and the subjects whose consultations were not replied on the same phone. Since there is no reference study framed in a similar design, at least 90 people (45 people for each group) were needed to obtain 80% power with 95% confidence as a result of the power analysis conducted in line with the assumptions, presuming that the effect size we expected from the study would be high (f = 0.6). The data will be analyzed with SPSS package program. Continuous variables were presented as median (IQR) while categorical variables will be provided as numbers and percentages. Kolmogrov-Smirnov analysis was used in normality distribution analysis. When the parametric assumptions were not met, the Mann-Whitney U test will be used to compare these differences. For all the analyses, P <0.05 will be considered statistically significant. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04645563
Study type Observational
Source Kafkas University
Contact
Status Completed
Phase
Start date March 11, 2020
Completion date May 31, 2020

See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure